GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $216,000 | -4.8% | 6,039 | -2.2% | 0.01% | -8.3% |
| Q4 2020 | $227,000 | -20.9% | 6,174 | -19.0% | 0.01% | -33.3% |
| Q3 2020 | $287,000 | -13.8% | 7,626 | -6.6% | 0.02% | -18.2% |
| Q2 2020 | $333,000 | +2.8% | 8,161 | -4.5% | 0.02% | -12.0% |
| Q1 2020 | $324,000 | -14.5% | 8,546 | +6.1% | 0.02% | +19.0% |
| Q4 2019 | $379,000 | +35.4% | 8,055 | +22.6% | 0.02% | +23.5% |
| Q3 2019 | $280,000 | +2.6% | 6,570 | -3.6% | 0.02% | 0.0% |
| Q2 2019 | $273,000 | -18.5% | 6,813 | -15.0% | 0.02% | -19.0% |
| Q1 2019 | $335,000 | +32.9% | 8,017 | +21.5% | 0.02% | +16.7% |
| Q4 2018 | $252,000 | +4.1% | 6,598 | +9.6% | 0.02% | +28.6% |
| Q3 2018 | $242,000 | -11.4% | 6,019 | -11.0% | 0.01% | -12.5% |
| Q2 2018 | $273,000 | -9.3% | 6,764 | -20.2% | 0.02% | -5.9% |
| Q4 2017 | $301,000 | +19.4% | 8,472 | +35.9% | 0.02% | +6.2% |
| Q3 2017 | $252,000 | -4.2% | 6,232 | +2.4% | 0.02% | -5.9% |
| Q2 2017 | $263,000 | -21.5% | 6,085 | -23.3% | 0.02% | -22.7% |
| Q1 2017 | $335,000 | +0.6% | 7,935 | -8.1% | 0.02% | -4.3% |
| Q4 2016 | $333,000 | -17.4% | 8,639 | -6.4% | 0.02% | -17.9% |
| Q3 2016 | $403,000 | -1.9% | 9,227 | -2.7% | 0.03% | -3.4% |
| Q2 2016 | $411,000 | +4.3% | 9,487 | -2.3% | 0.03% | 0.0% |
| Q1 2016 | $394,000 | +60.2% | 9,713 | +61.5% | 0.03% | +61.1% |
| Q4 2015 | $246,000 | -36.8% | 6,015 | -28.6% | 0.02% | -33.3% |
| Q1 2015 | $389,000 | +4.9% | 8,422 | -3.1% | 0.03% | -6.9% |
| Q4 2014 | $371,000 | -10.2% | 8,687 | -3.2% | 0.03% | -17.1% |
| Q3 2014 | $413,000 | -18.7% | 8,976 | -5.4% | 0.04% | -20.5% |
| Q2 2014 | $508,000 | +28.0% | 9,491 | +27.8% | 0.04% | +22.2% |
| Q1 2014 | $397,000 | +22.2% | 7,424 | +22.1% | 0.04% | +12.5% |
| Q4 2013 | $325,000 | -4.4% | 6,078 | -10.3% | 0.03% | -15.8% |
| Q3 2013 | $340,000 | -14.8% | 6,773 | -15.2% | 0.04% | -24.0% |
| Q2 2013 | $399,000 | – | 7,984 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |